Notice2021-21386
Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 1, 2021
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or Agency) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 188 (Friday, October 1, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 188 (Friday, October 1, 2021)]
[Notices]
[Pages 54457-54458]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21386]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2020-N-2231; FDA-2011-N-0362; FDA-2018-N-0073; FDA-
2018-N-0074; FDA-2010-N-0155; FDA-2011-N-0781; FDA-2021-N-0525; FDA-
2014-N-0987; FDA-2020-N-1657; FDA-2017-N-6931; FDA-2020-N-2217; FDA-
2012-N-0369; FDA-2017-N-6730; FDA-2020-N-1207; FDA-2012-N-0115; FDA-
2021-N-0363; FDA-2009-N-0025; FDA-2012-N-0547; FDA-2014-N-2347; FDA-
2018-N-1129; FDA-2021-N-0387; FDA-2020-N-1261; and FDA-2020-N-1644]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is publishing
a list of information collections that have been approved by the Office
of Management and Budget (OMB) under the Paperwork Reduction Act of
1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
<a href="/cdn-cgi/l/email-protection#cc9c9e8d9fb8adaaaa8caaa8ade2a4a4bfe2aba3ba"><span class="__cf_email__" data-cfemail="104042514364717676507674713e7878633e777f66">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
<a href="https://www.reginfo.gov/public/do/PRAMain">https://www.reginfo.gov/public/do/PRAMain</a>. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
[[Page 54458]]
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Blood Establishment Registration and 0910-0052 7/31/2024
Product Listing for Manufacturers of
Blood and Blood Products and Licensed
Devices................................
Current Good Manufacturing Practice: 0910-0139 7/31/2024
Manufacturing, Processing, Packing, and
Holding of Drugs; GMP for Finished
Pharmaceuticals (Including Gases and
Active Pharmaceutical Ingredients).....
Irradiation in the Production, 0910-0186 7/31/2024
Processing, and Handling of Food.......
State Enforcement Notifications......... 0910-0275 7/31/2024
Veterinary Feed Directive............... 0910-0363 7/31/2024
Record Retention Requirements for the 0910-0428 7/31/2024
Soy Protein/Coronary Heart Disease
Health Claim...........................
Prescription Drug Marketing: 0910-0435 7/31/2024
Administrative Procedures, Policies,
and Requirements.......................
Generic Clearance for the Collection of 0910-0796 7/31/2024
Qualitative Data on Tobacco Products
and Communications.....................
Survey of Drug Product Manufacturing, 0910-0899 7/31/2024
Processing, and Packing Facilities.....
Current Good Manufacturing Practices for 0910-0116 8/31/2024
Blood and Related Regulations for Blood
Components; and Requirements for Donor
Testing, Donor Notification and
``Lookback''...........................
New Animal Drugs for Investigational Use 0910-0117 8/31/2024
Regulations Under the Federal Import 0910-0212 8/31/2024
Milk Act...............................
Medical Device Reporting................ 0910-0437 8/31/2024
New Plant Varieties Intended for Food 0910-0583 8/31/2024
Use....................................
Guidance for Industry and FDA Staff; 0910-0594 8/31/2024
Class II Special Controls: Automated
Blood Cell Separator Device Operating
by Centrifugal or Filtration Separation
Principle..............................
Prescription Drug Advertisements........ 0910-0686 8/31/2024
Animal Food Labeling; Declaration of 0910-0721 8/31/2024
Certifiable Color Additives............
Survey on the Occurrence of Foodborne 0910-0744 8/31/2024
Illness Risk Factors in Selected Retail
and Food Service Facility Types........
Food and Cosmetic Export Certificates... 0910-0793 8/31/2024
National Agriculture and Food Defense 0910-0855 8/31/2024
Strategy Survey........................
Medical Product Communications That are 0910-0856 8/31/2024
Consistent With the Food and Drug
Administration Required Labeling--
Questions and Answers..................
Drug and Device Manufacturer 0910-0857 8/31/2024
Communications with Payors, Formulary
Committees, and Similar Entities
Questions and Answers..................
Study of Disclosures to Health Care 0910-0900 8/31/2024
Providers Regarding Data That Do Not
Support Unapproved Use of an Approved
Prescription Drug......................
Medical Conference Attendees' 0910-0901 8/31/2024
Observations About Prescription Drug
Promotion..............................
------------------------------------------------------------------------
Dated: September 24, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-21386 Filed 9-30-21; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 1, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.